LT97027A - Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse - Google Patents

Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse

Info

Publication number
LT97027A
LT97027A LT97-027A LT97027A LT97027A LT 97027 A LT97027 A LT 97027A LT 97027 A LT97027 A LT 97027A LT 97027 A LT97027 A LT 97027A
Authority
LT
Lithuania
Prior art keywords
rna
pharmaceuticals
increasing
amount
protein encoded
Prior art date
Application number
LT97-027A
Other languages
English (en)
Other versions
LT4475B (lt
Inventor
Virmantas Stunžėnas
Original Assignee
Virmantas Stunžėnas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virmantas Stunžėnas filed Critical Virmantas Stunžėnas
Priority to LT97-027A priority Critical patent/LT4475B/lt
Priority to PCT/LT1998/000001 priority patent/WO1998037900A1/en
Priority to JP53753298A priority patent/JP2001517215A/ja
Priority to GB9918974A priority patent/GB2337462A/en
Priority to DE19882018T priority patent/DE19882018T1/de
Publication of LT97027A publication Critical patent/LT97027A/lt
Publication of LT4475B publication Critical patent/LT4475B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LT97-027A 1997-02-28 1997-02-28 Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse LT4475B (lt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
LT97-027A LT4475B (lt) 1997-02-28 1997-02-28 Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
PCT/LT1998/000001 WO1998037900A1 (en) 1997-02-28 1998-02-24 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control
JP53753298A JP2001517215A (ja) 1997-02-28 1998-02-24 生理活性物質の生産におけるタンパク質に代わる又は特定免疫制御用の選択されたｒｎａの使用
GB9918974A GB2337462A (en) 1997-02-28 1998-02-24 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control
DE19882018T DE19882018T1 (de) 1997-02-28 1998-02-24 Verwendung der ausgewählten RNA anstelle eines Proteins bei der Produktion bioaktiver Substanzen oder für die spezifische Immunitätskontrolle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LT97-027A LT4475B (lt) 1997-02-28 1997-02-28 Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse

Publications (2)

Publication Number Publication Date
LT97027A true LT97027A (lt) 1998-09-25
LT4475B LT4475B (lt) 1999-02-25

Family

ID=19721814

Family Applications (1)

Application Number Title Priority Date Filing Date
LT97-027A LT4475B (lt) 1997-02-28 1997-02-28 Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse

Country Status (5)

Country Link
JP (1) JP2001517215A (lt)
DE (1) DE19882018T1 (lt)
GB (1) GB2337462A (lt)
LT (1) LT4475B (lt)
WO (1) WO1998037900A1 (lt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824411A1 (de) * 1978-06-03 1979-12-13 Boehringer Sohn Ingelheim Antiviral wirksame t-rna-praeparate
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2598619A1 (fr) * 1986-05-16 1987-11-20 Mafitra Management Services In Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU3418893A (en) * 1991-12-24 1993-07-28 Immune Response Corporation, The Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
CA2110946A1 (en) 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
IL112873A (en) * 1994-03-08 2005-03-20 Wyeth Corp Rapamycin-fkbp12 binding proteins, their isolation and their use

Also Published As

Publication number Publication date
WO1998037900A1 (en) 1998-09-03
LT4475B (lt) 1999-02-25
GB9918974D0 (en) 1999-10-13
JP2001517215A (ja) 2001-10-02
DE19882018T1 (de) 2000-01-13
GB2337462A (en) 1999-11-24

Similar Documents

Publication Publication Date Title
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
HUP0104296A3 (en) Cross-linked hyaluronic acids, uses thereof and biological substances containing them
HU9800075D0 (en) Nucleic acid construct for expressing active substances wich can be activated by proteases, and preparation and use
HUP0203506A3 (en) Modified peptides as therapeutic agents
GB2328014B (en) Improvements in or relating to personal radiation dosemeters
HUP0001937A3 (en) Compounds, preparation and use for transferring nucleic acids into cells
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
GB9603069D0 (en) Improvements in or relating to gene expression
AU8990298A (en) Improvements in or relating to contrast agents
HUP0104825A3 (en) Genes and proteins, and their use
HUP9900317A3 (en) Pharmaceutical composition useful for nucleic acid transfection, and use thereof
FI963716L (fi) Glykolyyttisen reitin entsyymejä koodittava, alkoholia tuottavissa hiivoissa käytettävä DNA
IL120634A0 (en) Ion - exchange spacer and processes for the preparation thereof
GB9725953D0 (en) Compounds useful in therapy
AU8816198A (en) Improvements in or relating to contrast agents
HUP0002329A3 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
IT1279079B1 (it) Vibratore,in particolare per laboratorio dentistico
AU1959200A (en) New utilization of alpha-hidroxy-propionic acid in medicine
GB9722287D0 (en) Compounds useful in therapy
GB2333776B (en) Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means
GB9706277D0 (en) Improvements in or relating to construction sets
AU2001292027A1 (en) Methods relating to polymorphisms in the human gpr10 gene
AU5324399A (en) Human epidermal proteins hepi-1 to hepi-6

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20020228